Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.

This publication has 19 references indexed in Scilit:

• CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines
  Environmental Toxicology and Pharmacology, 1996
• In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
  1995
• Expression of cytochrome P‐450 3A in HT29‐MTX cells and Caco‐2 clone TC7
  FEBS Letters, 1994
• Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.
  1994
• Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily
  Biochemical Pharmacology, 1994
• Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
  1993
• Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
  Journal of Clinical Investigation, 1992
• Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases.
  1992
• Cell cultures as models for drug absorption across the intestinal mucosa.
  1991
• The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
  Pharmaceutical Research, 1990